Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Hope

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
Antimicrobial Agents and Chemotherapy|November 28, 2018
Correction for Stott et al., "Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis"Katharine E Stott, Justin Beardsley, Ruwanthi Kolamunnage-Dona, et al.
The Journal of Infection|November 1, 2025
Target product profile and discovery and development path for novel cryptococcal disease treatmentsDavid B Meya, Manu De Rycker, Ian H Gilbert, et al.
Journal of Surgical Education|October 11, 2020
Impact of Surgery Program Characteristics on Fate of Non-designated Preliminary Surgery InternsKaitlin A Ritter, Rahul J Anand, Kathleen Beard, et al.
The Journal of Antimicrobial Chemotherapy|May 9, 2019
Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat modelSean N Avedissian, Gwendolyn M Pais, J Nicholas O'Donnell, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Software for Dosage Individualization of Voriconazole: a Prospective Clinical StudyWilliam Hope, Gary Johnstone, Silvia Cicconi, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal DiseaseGemma L Nixon, Laura McEntee, Adam Johnson, et al.
Critical Care (London, England)|February 19, 2020
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trialAdela Benítez-Cano, Sonia Luque, Luisa Sorlí, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2023
Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitisCharles D Giamberardino, Jennifer L Tenor, Dena L Toffaletti, et al.
Nature Microbiology|April 9, 2025
Author Correction: Combining antibiotics to tackle antimicrobial resistanceWilliam Hope, Sumathi Nambiar, Seamus O'Brien, et al.
The Journal of Clinical Investigation|January 29, 2019
Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitisNeil Rh Stone, Johanna Rhodes, Matthew C Fisher, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|November 28, 2018
Correction for Stott et al., "Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis"Katharine E Stott, Justin Beardsley, Ruwanthi Kolamunnage-Dona, et al.
The Journal of Infection|November 1, 2025
Target product profile and discovery and development path for novel cryptococcal disease treatmentsDavid B Meya, Manu De Rycker, Ian H Gilbert, et al.
Journal of Surgical Education|October 11, 2020
Impact of Surgery Program Characteristics on Fate of Non-designated Preliminary Surgery InternsKaitlin A Ritter, Rahul J Anand, Kathleen Beard, et al.
The Journal of Antimicrobial Chemotherapy|May 9, 2019
Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat modelSean N Avedissian, Gwendolyn M Pais, J Nicholas O'Donnell, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Software for Dosage Individualization of Voriconazole: a Prospective Clinical StudyWilliam Hope, Gary Johnstone, Silvia Cicconi, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal DiseaseGemma L Nixon, Laura McEntee, Adam Johnson, et al.
Critical Care (London, England)|February 19, 2020
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trialAdela Benítez-Cano, Sonia Luque, Luisa Sorlí, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2023
Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitisCharles D Giamberardino, Jennifer L Tenor, Dena L Toffaletti, et al.
Nature Microbiology|April 9, 2025
Author Correction: Combining antibiotics to tackle antimicrobial resistanceWilliam Hope, Sumathi Nambiar, Seamus O'Brien, et al.
The Journal of Clinical Investigation|January 29, 2019
Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitisNeil Rh Stone, Johanna Rhodes, Matthew C Fisher, et al.
Pageof 16